HIFIBIO
HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.
HIFIBIO
Industry:
Biopharma Biotechnology Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.hifibio.com
Total Employee:
101+
Status:
Active
Contact:
+33179350790
Total Funding:
179.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Apache Wordpress Plugins
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-10-15 | H-Immune Therapeutics | H-Immune Therapeutics acquired by HiFiBiO | N/A |
Investors List
Grand Mount Capital
Grand Mount Capital investment in Series D - HiFiBiO
IDG Capital
IDG Capital investment in Series D - HiFiBiO
Mirae Asset Capital
Mirae Asset Capital investment in Series D - HiFiBiO
Legend Star
Legend Star investment in Series D - HiFiBiO
Maison Capital
Maison Capital investment in Series D - HiFiBiO
Sequoia Capital China
Sequoia Capital China investment in Series D - HiFiBiO
Hengxu Capital
Hengxu Capital investment in Series D - HiFiBiO
Sherpa Venture Capital
Sherpa Venture Capital investment in Series D - HiFiBiO
B Capital Group
B Capital Group investment in Series D - HiFiBiO
Hong Kong Science and Technology Parks Corporation (HKSTP)
Hong Kong Science and Technology Parks Corporation (HKSTP) investment in Series D - HiFiBiO
Official Site Inspections
http://www.hifibio.com Semrush global rank: 5.53 M Semrush visits lastest month: 1.54 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "HiFiBiO"
HiFiBiO - Crunchbase Company Profile & Funding
HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires …See details»
About - HiFiBio Therapeutics
HiFiBiO Therapeutics is a clinical-stage biotech driving a pipeline of transformative immunotherapies. About. Company Overview; Leadership; Scientific Advisory Board; Board of …See details»
Company Overview - HiFiBio Therapeutics
CEO Liang Schweizer Sits with Nasdaq to Share HiFiBiO Therapeutics’ Mission to Unlock the Curative Powers of the Immune System Biotech2050 | Podcast | Jun 14, 2023 HiFiBiO Therapeutics CEO Liang Schweizer Shares Her …See details»
HiFiBiO Therapeutics - LinkedIn
HiFiBiO Therapeutics is a clinical-stage global biotech pioneering a unique high-resolution translational solution (DIS®, Drug Intelligence Science) to enhance the probability of success for ...See details»
HiFiBiO - Org Chart, Teams, Culture & Jobs - The Org
HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise …See details»
HiFiBiO Therapeutics Company Profile 2024: Valuation, Funding ...
HiFiBiO Therapeutics was founded in 2013. Where is HiFiBiO Therapeutics headquartered? HiFiBiO Therapeutics is headquartered in Cambridge, MA. What is the size of HiFiBiO …See details»
HiFiBio SAS - life-sciences-europe.com
HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise …See details»
HiFiBio (HK) Limited - hkstp.org
HiFiBiO Therapeutics is a clinical stage biotech company advancing a robust pipeline targeting both the innate and adaptive immunity to treat cancer and autoimmune disease. Our …See details»
HiFiBiO Inc - MassBio
HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise …See details»
Leadership - HiFiBio Therapeutics
Prior to HiFiBiO, Tim worked as the Director of Business of Development for ImmunoPrecise Antibodies where he led the company’s licensing and partnerships opportunities across all five …See details»
HiFiBiO - Contacts, Employees, Board Members, Advisors & Alumni
Organization. HiFiBiO . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 8. Number of Board …See details»
HiFiBiO - Funding, Financials, Valuation & Investors - Crunchbase
HiFiBiO has acquired H-Immune Therapeutics on Oct 15, 2018. Unlock for free . Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 5. ... How much funding has this …See details»
HiFiBiO gets high-five from investors with $75M series D to bring 2 ...
Jun 14, 2021 HiFiBiO’s name has a sense of urgency to it when spoken aloud. That urgency comes into play today with an oversubscribed $75 million series D to bring two lead antibody …See details»
Join Us - HiFiBio Therapeutics
We adjust rapidly as our organization grows and are ready to take on new challenges. We empower decision making for individuals while aligning closely under our shared vision, …See details»
HiFiBiO - Updates, News, Events, Signals & Triggers - Crunchbase
HiFiBiO may be growing as it successfully closed a $75 million series D funding round, which is a significant financial milestone indicating investor confidence and the availability of capital for …See details»
HiFiBiO SAS Achieves Milestone in Antibody Research ... - Pfizer
PARIS, FRANCE, Aug. 13, 2015 – HiFiBiO SAS announced today the company has achieved a milestone in its research collaboration with Pfizer Inc., triggering a milestone payment to …See details»
FibroGen and HiFiBiO Announce Transformative Partnership to
Jun 17, 2021 HiFiBiO to Receive $25 Million Upfront, and Up to a Total of $1.1B in Additional Milestone Payments Across All Three Programs, Plus Royalties; SAN FRANCISCO and …See details»
Scientific Founders - HiFiBio Therapeutics
HiFiBiO Therapeutics is a clinical-stage biotech driving a pipeline of transformative immunotherapies. About. Company Overview; Leadership; ... epigenetics—changes in gene …See details»
News - HiFiBio Therapeutics
HiFiBiO Therapeutics Receives FDA Clearance of IND Application for HFB200604, a Best-in-Class BTLA Agonist Antibody for the Treatment of Inflammatory and Immunology Diseases All …See details»